WJ-MSCs (Wharton's Jelly mesenchymal stem cells)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for WJ-MSCs (Wharton's Jelly mesenchymal stem cells), covering 2019-07-09 to 2019-07-09. Get the full timeline:
Most recent: Clinical Trial Update: Randomized Study of Coronary Revascularization Surgery With Injection of WJ-MSCs and Placement of an Epicardial Extracellular Matrix [Phase 1, Phase 2]